Safety, Efficacy, and Visual Performance of an Orthokeratology Lens with Increased Compression Factor

Elena Martínez-Plaza,Cecilia Zamora Castro,Ainhoa Molina-Martín,David P. Piñero
DOI: https://doi.org/10.3390/jcm13020587
IF: 3.9
2024-01-20
Journal of Clinical Medicine
Abstract:The aim was to evaluate the safety, efficacy, and visual performance of an orthokeratology lens with an increased compression factor (ICF) of 1.25 D in a 3-month follow-up. Thirty-six myopic patients (5 males and 31 females; 24.2 ± 5.8 years) were fitted with Alexa AR (Tiedra Farmacéutica S.L., Madrid, Spain) contact lenses (CLs) and twenty participants finished the follow-up. Visual acuity (VA), subjective refraction, primary spherical and primary coma aberrations, keratometry, central pachymetry, and ocular surface evaluation were performed at baseline and after 1 night, 1 week, 1 month, and 3 months of CL wear. The differences among visits were analyzed using a repeated-measures analysis of variance or the Friedman test. The spherical equivalent decreased (p ≤ 0.005), and the uncorrected VA improved (p < 0.001) until the first week. Corneal and ocular aberrations showed a significant increase (p ≤ 0.02). A significant decrease (p < 0.001) was found for keratometry values. No significant changes were observed in either central pachymetry or ocular surface parameters among study visits. In conclusion, an orthokeratology CL with an ICF of 1.25 D provides good safety, efficacy, and visual performance in a 3-month follow-up. Seven days of orthokeratology wear are enough to achieve the full myopic compensation, resulting in satisfactory VA.
medicine, general & internal
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to evaluate the safety, effectiveness and visual performance of an orthokeratology lens with an increased compression factor (ICF) of 1.25 D during a 3 - month follow - up period. Specifically, the study focuses on the following aspects: 1. **Safety**: Evaluate whether the eye health is affected after wearing this orthokeratology lens, including the changes in indicators such as corneal thickness and ocular surface parameters. 2. **Effectiveness**: Evaluate the effect of this orthokeratology lens in correcting myopia, including the changes in uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA). 3. **Visual performance**: Evaluate the visual quality after wearing this orthokeratology lens, including the changes in high - order aberrations such as spherical aberration and coma. The study analyzed the changes in these indicators by comparing the data at baseline and different time points (1 night, 1 week, 1 month, 3 months) to evaluate whether the design of this orthokeratology lens can effectively and safely correct myopia and provide a good visual experience.